Novo Nordisk (NVO) Stock Overview

Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Rare Disease. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, glucagon, needles, and other chronic diseases. The Rare Disease segment offers products in the areas of haemophilia, blood disorders, endocrine disorders, growth disorders, and hormone replacement therapy. The company has a collaboration agreement with Gilead Sciences, Inc.; and research collaboration with Novo Nordisk to discover cell-specific carriers of nucleic acid therapeutics. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

NVO Stock Information

Symbol

NVO

Address

Novo Alle 1Bagsvaerd, 2880Denmark

Founded

Trading hours

9:30 AM - 4:00 PM ET

Website

https://www.novonordisk.com

Country

🇩🇰 Denmark

Phone Number

45 44 44 88 88

Novo Nordisk (NVO) Price Chart

Novo Nordisk Overview: Key Details and Summary

Stock data	2023	Change
Price	$84.91	N/A
Market Cap	$380.63B	N/A
Shares Outstanding	4.48B	-1.06%
Employees	61.41K	N/A
Shareholder Equity	106.56B	27.64%

Valuation	2023	Change
P/E Ratio	4.56	N/A
P/S Ratio	11.79	N/A
P/B Ratio	3.57	N/A
P/FCF	39.13	N/A
POE	0.00	N/A

Dividends	2023	Change
Dividend Yield	1.16%	N/A
Dividend per share	0.9847	N/A
Dividend Payout Ratio	0.3796	N/A

Growth	2023	Change
ROIC	0.4931	N/A
CAPEX	-3.59B	N/A
Return on Equity	0.1091	N/A

Earnings	2023	Change
Revenue	$32.27B	N/A
Earnings	$11.63B	N/A
Free Cash Flow	$9.73B	N/A
EPS	18.62	N/A
Earnings Yield	0.2193	N/A
Gross Margin	0.846	N/A
Operating Margin	0.4416	N/A
Net income margin	0.3603	N/A
FCF Margin	0.3014	N/A

Financial Strength	2023	Change
Total Assets	$43.70B	N/A
Total Debt	$3.75B	N/A
Cash on Hand	$4.20B	N/A
Debt to Equity	0.2711	3.25%
Cash to Debt	$1.12	22.43%
POE	0.0000	N/A
Current Ratio	0.8231	-7.99%

Other data	2023	Change
Buyback Yield	0.0109	N/A